What is the ELVN stock price prediction for next 2 weeks?

According to our price prediction algorithm,Enliven Therapeutics, Inc. (ELVN) price will be around $31.43 in the next 2 weeks. This means it will increase by 0.8969502407704737 from the last closing price. This prediction may vary from other time period filters for ELVN stock.

What can be the highest Possible price of ELVN stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, ELVN can achieve the highest price of $32.73 which is 5.080391604478217 higher than last closing price. This prediction may vary from other time period filters for ELVN stock.

What can be the lowest Possible price of ELVN stock in next 2 weeks?

As per the forecast and algorithmic analysis, ELVN stock price can be as low as $29.95 which is -3.8663709504899764 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for ELVN stock.

Will ELVN stock go high in the next 2 weeks?

Yes, our stock forecasting algorithm shows that ELVN stock will gain0.8969502407704737 in the next 2 weeks. This prediction may vary from other time period filters for ELVN stock.

What is ELVN stock last closing price?

Last closing price of ELVN stock was $31.15.

What is ELVN stock price prediction?

ELVN stock price prediction means predicting the future closing prices of ELVN stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of ELVN stock in a certain time period.

How we predict ELVN stock future prices?

If you are searching for ELVN stock forecast, analysis or price prediction, then you might be wondering what Enliven Therapeutics, Inc. (ELVN) will do in the future. Our ELVN price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This ELVN price prediction will likely answer most of your questions.

How frequent we update ELVN stock predictions?

We are updating the forecasts for the ELVN stock on daily basis.

Is using ML forecasting for ELVN stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for ELVN stock same for all the time periods?

No, the prediction for ELVN stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Enliven Therapeutics, Inc. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$31.151.47%Since 2 Weeks

Predicted Price$31.430.9%For 2 Weeks

Upper Predicted Price$32.735.08%For 2 Weeks

Lower Predicted Price$29.95-3.87%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of ELVN will rise by +0.90% over the next 2 Weeks and hit $31.43 by Tuesday, April 7, 2026. In that time frame, ELVN's share price is expected to range between $29.95 and $32.73.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Apr 7, 2026	29.95	31.43	32.73
Apr 6, 2026	30.10	31.59	32.91
Apr 3, 2026	29.81	31.22	32.53
Apr 2, 2026	29.67	31.19	32.64
Apr 1, 2026	29.92	31.30	32.80
Mar 31, 2026	29.78	31.16	32.63
Mar 30, 2026	29.88	31.32	32.73
Mar 27, 2026	29.48	30.95	32.35
Mar 26, 2026	29.49	30.92	32.38
Mar 25, 2026	29.60	31.03	32.48

ELVN shares rose +1.10% in Tuesday, March 24, 2026's trading session, rising from a previous close of $30.81 to move at $31.15. The stock demonstrated notable intraday movement (see ELVN's key stats for a full breakdown), fluctuating between $29.44 and $31.32, a +6.39% trading range. While recent weeks have seen some volatility, ELVN has managed to secure a +1.47% gain over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 1.21M shares changing hands, 321.63K more than the previous session. This amounted to $37.66M in total market activity.

Will ELVN Continue Its Upward Trend?

According to analyst ratings and projections for ELVN, Enliven Therapeutics, Inc. shares are anticipated to increase by +4.83%, potentially reaching $32.73 per share by April 7, 2026. Short-term technical indicators currently suggest a neutral sentiment for ELVN. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 16 positive trading days within the past 30 sessions. Based on the ELVN stock forecast, now is a good time to buy ELVN stock because its current trading price is -0.89% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on ELVN covering social and institutional perspectives.

ELVN Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into ELVN's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 60.55% to 63.54%) suggest the stock is in a bullish momentum phase. The 50-day RSI, at 58.14%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 55.55%, maintains a neutral outlook for the long term. Insights into ELVN's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Enliven Therapeutics Short-Term Forecasts

ELVN Forecast For Next 5 Days

Our algorithm anticipates Enliven Therapeutics (ELVN) stock could hit $27.54 by Mar 31, 2026. This represents a -11.58% rise from today's price, following a +8.07% change over the past five days.

ELVN Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Enliven Therapeutics, Inc. (ELVN) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $28.24, which would mean a -9.34% decrease from the current price of $31.15. Projections for this period range from a high of $33.92 to a low of $22.98.

ELVN Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Enliven Therapeutics's price over the next three months point to a rise. ELVN stock is expected to peak at $35.36 on Jun 17, 2026 after potentially dipping to $28.20 on Apr 06, 2026. On average, ELVN is likely to trade around $31.42 in the coming 90 days.

Enliven Therapeutics Stock Forecast 2025

Based on our predictive models, Enliven Therapeutics (ELVN) is expected to trade between $28.20 and $38.29 throughout 2026. This would result in an average price of $32.09, potentially offering investors a +3.02% return from current levels.

Enliven Therapeutics, Inc. Monthly Forecast 2026–2027

March 2026

According to our latest forecast models, Enliven Therapeutics, Inc. (ELVN) is positioned to show a strong performance in March 2026. The price is predicted to move between $28.56 and $32.39, settling at an average of $30.51. This could translate to a -2.05% loss.

April 2026

Based on current market signals, Enliven Therapeutics, Inc. is projected to trend april 2026. We forecast a trading range from $28.20 to $32.97, with a likely average price of $30.84. Investors could expect a potential return of -1.00%.

May 2026

Our predictive algorithms indicate Enliven Therapeutics, Inc. stock may see a shift in May 2026. The expected range spans $28.99–$33.11, with an average target of $30.99. This represents a cautious outlook and a possible loss of -0.51%.

June 2026

Analyzing established trends, Enliven Therapeutics, Inc. looks set to move in June 2026. Projections place the stock between $29.81 and $35.36, averaging around $32.78. This suggests a +5.23% gain from current levels.

July 2026

Market indicators suggest Enliven Therapeutics, Inc. could experience notable changes during July 2026. Prices could fluctuate within $30.51 to $34.04, with a midpoint forecast of $32.33. The stock might deliver a +3.79% gain.

August 2026

Forecasting for August 2026, models estimate that Enliven Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $29.15 and $33.94, averaging $31.87. This signals a positive trajectory with potential returns around +2.31%.

September 2026

According to our latest forecast models, Enliven Therapeutics, Inc. (ELVN) is positioned to show a strong performance in September 2026. The price is predicted to move between $29.13 and $33.67, settling at an average of $31.65. This could translate to a +1.61% gain.

October 2026

Based on current market signals, Enliven Therapeutics, Inc. is projected to trend october 2026. We forecast a trading range from $29.73 to $33.85, with a likely average price of $31.78. Investors could expect a potential return of +2.02%.

November 2026

Our predictive algorithms indicate Enliven Therapeutics, Inc. stock may see a shift in November 2026. The expected range spans $31.06–$38.29, with an average target of $33.79. This represents a positive outlook and a possible gain of +8.48%.

December 2026

Analyzing established trends, Enliven Therapeutics, Inc. looks set to move in December 2026. Projections place the stock between $31.30 and $34.81, averaging around $33.06. This suggests a +6.13% gain from current levels.

January 2027

Market indicators suggest Enliven Therapeutics, Inc. could experience notable changes during January 2027. Prices could fluctuate within $29.79 to $34.90, with a midpoint forecast of $32.45. The stock might deliver a +4.17% gain.

February 2027

Forecasting for February 2027, models estimate that Enliven Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $30.00 and $34.42, averaging $32.47. This signals a positive trajectory with potential returns around +4.24%.

March 2027

According to our latest forecast models, Enliven Therapeutics, Inc. (ELVN) is positioned to show a strong performance in March 2027. The price is predicted to move between $30.49 and $34.43, settling at an average of $32.40. This could translate to a +4.01% gain.

ELVN's history of dividends and stock splits also plays a role in long-term investor confidence.